OQRO

Weekly recap

Insider trades and Congress trades, week of Feb 16–22, 2026

In the week of Feb 16–22, 2026, insiders filed 170 open-market purchases worth about $155M and 1,173 open-market sales; the largest purchase was $21.2M of W. R. Berkley Corporation (WRB) by MITSUI SUMITOMO INSURANCE CO LTD; members of Congress disclosed 13 purchases and 18 sales; 10 purchases stood out against the company's record since 2006.

By filing date, Monday to Sunday. Every line links to its SEC, House or Senate record. Public filings, not investment advice.

Purchases that stand out against 20 years of filings

Measured against every open-market trade the company's insiders filed since 2006. See all of them on the rare insider trades page.

Largest insider purchases

Largest insider sales

Congress trades disclosed

Members report a value range, not an exact amount; the trade can be up to 45 days older than its report.

Executives who announced they are leaving

  • Domino's (DPZ) · Feb 20, 2026

    “On February 18, 2026, James A. Goldman informed Domino’s Pizza, Inc. (the “Company”) that, after more than 15 years of service on the Company’s Board of Directors (the “Board”), he has decided to retire from the Board and thus shall not stand for reelection to the Board at the Company’s 2026 Annual Meeting of Shareholders in April.” 8-K

  • Erie Indemnity (ERIE) · Feb 20, 2026

    “On February 20, 2026, Erie Indemnity Company (the “Company”) issued a press release announcing that Timothy G. NeCastro, the Company’s President and Chief Executive Officer, will retire on December 31, 2026 and the Board of Directors of the Company will initiate a search to identify a new President and Chief Executive Officer.” 8-K

  • Sonoco (SON) · Feb 20, 2026

    “On February 19, 2026, the Company and Mr. Fuller agreed to amend the effective date of his retirement as the Company’s Chief Operating Officer to April 11, 2026.” 8-K

  • Bruker (BRKR) · Feb 20, 2026

    “On February 16, 2026, Dr. Cynthia M. Friend informed the Board of Directors (“Board”) of Bruker Corporation (the “Company”) of her decision not to stand for re-election as a Class II director when her current term expires at the Company’s 2026 Annual Meeting of Stockholders (“2026 Annual Meeting”).” 8-K

  • Daktronics Inc /Sd/ (DAKT) · Feb 20, 2026

    “On February 16, 2026, the Board of Directors of Daktronics, Inc. (the “ Company ”) authorized the Company to enter into an Amended and Restated Termination Agreement and General Release of Claims, effective as of February 1, 2026 (the “ Effective Date ”), with Bradley T. Wiemann, the former Interim President and Chief Executive Officer (“ CEO ”) of the Company (the “ Amended Agreement ”).” 8-K

  • Skye Bioscience (SKYE) · Feb 20, 2026

    “On February 13, 2026, the Company and Kaitlyn Arsenault determined that Ms. Arsenault will step down from her position as Chief Financial Officer of the Company, effective February 20, 2026 (the “Separation Date”) to pursue new professional opportunities.” 8-K

  • Exxon Mobil (XOM) · Feb 20, 2026

    “On February 18, 2026, Mr. Jeffrey W. Ubben announced his intention not to stand for re-election to the board at the annual meeting of shareholders on May 27, 2026, for reasons unrelated to the company.” 8-K

  • Kala Bio (KALA) · Feb 20, 2026

    “On February 16, 2026, David Lazar notified KALA BIO, Inc. (the “ Company ”) of his decision to resign as a member of the Board of Directors of the Company, effective as of the same date.” 8-K

The company's own words, from the opening sentence of its Form 8-K (Item 5.02).

5% stakes filed (Schedules 13D and 13G)

Largest federal contract awards

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen KKR & Co. free$9.99 a month, cancel anytime